Lincopharco

Nazione: Egitto

Lingua: inglese

Fonte: EDA (Egyptian Drug Authority)

Principio attivo:

Lincomycin hydrochloride monohydrate 37.76 g ( Equivalent to Lincomycin 33.3 g ) + Spectinomycin sulfate tetrahydrate 100.8 g ( Equivalent to Spectinomycin 66.7 g ) / 150 g

Commercializzato da:

Pharco Pharmaceuticals – Egypt

Forma farmaceutica:

Water soluble powder

Prodotto da:

Pharco Pharmaceuticals – Egypt

Prodotti simili

Principio attivo Lincomycin hydrochloride monohydrate 37.76 g ( Equivalent to Lincomycin 33.3 g ) + Spectinomycin sulfate tetrahydrate 100.8 g ( Equivalent to Spectinomycin 66.7 g ) / 150 g

Lincomycin hydrochloride monohydrate 37.76 g ( Equivalent to Lincomycin 33.3 g ) + Spectinomycin sulfate tetrahydrate 100.8 g ( Equivalent to Spectinomycin 66.7 g ) / 150 g

Commercializzato da Pharco Pharmaceuticals – Egypt

Pharco Pharmaceuticals – Egypt

Cerca alert relativi a questo prodotto

Avvisi Lincopharco Lincomycin hydrochloride monohydrate 37.76

Lincopharco Lincomycin hydrochloride monohydrate 37.76

Visualizza cronologia documenti

Cronologia dei documenti Cronologia dei documenti

Lincopharco